Next Article in Journal
Photodecomposition and Phototoxicity of Natural Retinoids
Previous Article in Journal
Effect of Co-Existing Biologically Relevant Molecules and Ions on DNA Photocleavage Caused by Pyrene and its Derivatives
Article Menu

Export Article

Open AccessArticle
Int. J. Environ. Res. Public Health 2005, 2(1), 138-146; doi:10.3390/ijerph2005010138

Effects of Pristane on Cytochrome P450 Isozyme Expression in Rat Tissues

Breast Cancer Research Laboratory, Department of Biology, and NIH-Center for Environmental Health, College of Science, Engineering and Technology, Jackson State University, 1400 Lynch Street, P. O. Box 18540, Jackson, Mississippi, USA
Laboratory for Cancer Research, College of Pharmacy, Rutgers University, Piscataway, NJ 08855-0789, USA
Department of Microbiology, University of Mississippi Medical Center, Jackson, MS 39216-4505, USA
Author to whom correspondence should be addressed.
Received: 15 November 2004 / Accepted: 6 February 2005 / Published: 30 April 2005
View Full-Text   |   Download PDF [836 KB, uploaded 19 June 2014]   |  


Chemical carcinogenesis studies are powerful tools to obtain information on potential mechanisms of chemical factors for malignancies. In this study Western blot analyses, using monoclonal antibodies specific for three different cytochrome P450 (CYP) isozymes (CYP1A1, CYP1A2 and CYP2B), were employed to examine the effect(s) of 3-methylcholanthrene and/or pristane (2,6,10,14-tetramethylpentadecane) on the basal and inducible levels of expression of CYP proteins within Copenhagen rat tissues. Pristane exposure led to tissue specific differences in the CYP isozymes expressed and elicited increased CYP protein expression over 3-methylcholanthrene induced levels in microsomes isolated from liver, Peyer's Patches, and thymus. Within the context of the chemical carcinogenesis model employed in this study, these observations correlated with the induction of B-cell malignancies by low doses of 3-methylcholanthrene and of thymic lymphomas by a high 3-methylcholanthrene dose. The data suggest that pristane treatment affects CYP isozyme expression. This pristane-mediated effect clearly could be a contributing factor in the chemical carcinogenesis of the previously observed lymphoid malignancies, and a possible basis for the tumor enhancing effects of pristane. View Full-Text
Keywords: Pristane; Cytochrome P450 (CYP); monoclonal antibodies; 3-methylcholanthrene; phenobarbital; Western blots Pristane; Cytochrome P450 (CYP); monoclonal antibodies; 3-methylcholanthrene; phenobarbital; Western blots

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Howard, C.B.; Samuel, J.; Henderson, S.B.; Stevens, J.; Thomas, P.E.; Cuchens, M.A. Effects of Pristane on Cytochrome P450 Isozyme Expression in Rat Tissues. Int. J. Environ. Res. Public Health 2005, 2, 138-146.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Int. J. Environ. Res. Public Health EISSN 1660-4601 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top